Biosimilars in rheumatic diseases: structural and functional variability that may impact clinical and regulatory decisions

A Lakhanpal, E Brahn - Clinical rheumatology, 2016 - Springer
Biologics as therapeutic interventions for human disease represent both a distinctly modern
novelty and an echo of ancient, or at least old, medical practice. The similarity lies in the …

Why do patients have doubts about generic drugs in Italy?

L Pasina, SAM Urru, S Mandelli… - European Journal of …, 2016 - Springer
The consumption of generic drugs differs widely among European countries, ranging from
about 10–15%(Poland, Hungary, Romania, Czech, Slovakia, Ireland, and Italy) to above …

[HTML][HTML] Eficacia en el control de la anticoagulación de los diferentes fármacos antagonistas de la vitamina K disponibles en Chile

D Rodríguez, E Nieto, T Quiroga, E Rojas… - Revista médica de …, 2020 - SciELO Chile
En la actualidad, el uso de fármacos anticoagulantes orales constituye una herramienta
esencial para la prevención primaria y secundaria de eventos tromboembólicos en diversas …

Controverse dans la corticothérapie des vascularites systémiques

JC Lega, S Durupt, Q Reynaud, DV Durand… - Revue du rhumatisme …, 2017 - Elsevier
Résumé La corticothérapie est la pierre angulaire du traitement des vascularites
systémiques. Cependant, du fait du faible nombre d'essais randomisés évaluant les …

[HTML][HTML] Perspectives of patients and consumers on the use of generic medicines

N Celedón, C González, C Cuadrado - Medwave, 2021 - viejo.medwave.cl
METHODS We searched in Epistemonikos, the largest database of systematic reviews in
health, which is maintained by screening multiple information sources, including MEDLINE …

[HTML][HTML] The role of county-level socioeconomic status on brand-name prescriptions in Medicare part D: A cross-sectional Study

C Volpi, F Shehadeh, E Mylonakis - Medicine, 2020 - journals.lww.com
The role of county-level socioeconomic status on brand-name... : Medicine The role of
county-level socioeconomic status on brand-name prescriptions in Medicare part D: A cross-sectional …

Validation of HPLC and liquid-liquid extraction methods for warfarin detection in human plasma and its application to a pharmacokinetics study

YA Chua, WZ Abdullah, Z Yusof… - ASM Science …, 2019 - research.monash.edu
A reversed-phase HPLC method to determine total plasma warfarin was developed and
validated. Warfarin was extracted from human plasma using a two-step liquid-liquid …

[HTML][HTML] Examining therapeutic equivalence between branded and generic warfarin in Brazil: The WARFA crossover randomized controlled trial

C Gomes Freitas, M Walsh, EL Coutinho… - Plos one, 2021 - journals.plos.org
Objectives To determine whether the generic and branded warfarins used as anticoagulants
in Brazil are therapeutic equivalents based on their international normalized ratio (INR) …

Withdrawal of two generic clopidogrel products in Saudi Arabia for non-bio-equivalence

AS Alsultan, HA Hakeam - Annals of Saudi Medicine, 2018 - annsaudimed.net
To the Editor: Clopidogrel, a P2Y12 platelet inhibitor, is indicated for the treatment of
cardiovascular and cerebrovascular events. 1-3 In February 2018, the Saudi Food and Drug …

[HTML][HTML] Evaluation of knowledge, attitude, and practice of generic drugs among intern doctors at a tertiary care teaching hospital

KR Tandel, SN Bhadiyadara, SM Zaiwala - National Journal of …, 2019 - njppp.com
Background: The increasing health-care expenses are a major concern for the health-care
proving system in the world. As stated by the World Health Organization, in the majority of …